Japan Dengue Testing Market Size, Share, and COVID-19 Impact Analysis, By Test Type (ELISA-based Tests, Dengue IgG/IgM Detection Kits, RT-PCR Tests, Rapid Diagnostic Tests (RDTs), NS1 Antigen Detection Kits and Lateral Flow Immunoassay), By End Use (Clinical Labs, Hospitals /Clinics and Home Healthcare), and Japan Dengue Testing Market Insights, Industry Trend, Forecasts to 2035

Japan Dengue Testing Market Insights Forecasts to 2035

• The Japan Dengue Testing Market Size is Expected to Grow at a CAGR of around 4.8% from 2025 to 2035
• The Japan Dengue Testing Market Size is Expected to Hold a Significant Share by 2035

According to a Research Report Published by Spherical Insights & Consulting, the Japan Dengue Testing Market Size is Anticipated to Hold a Significant Share by 2035, Growing at a CAGR of 4.8% from 2025 to 2035. The Japan dengue testing market is driven by various factors, including the rise in the incidence of dengue cases, the rising importance of early detection and treatment, support from the government, and technological advancements in diagnostic kits.

Market Overview

The dengue tests are performed for early diagnosis and management of dengue fever. Dengue is a viral infection caused by to bite of an infected mosquito. Dengue is diagnosed by various tests, including enzyme-linked immunosorbent assay (ELISA), RT-PCR, and dengue IgG/IgM rapid tests. The rise in dengue cases is expected to drive the market. Healthcare centres and governments are embracing new testing techniques, such as molecular diagnostics, serological tests, and rapid antigen testing, to enable early diagnosis and effective control of the disease. Additionally, point-of-care and home testing kits are commonly used due to their simplicity and the immediate results they provide. The rising burden of dengue presents an opportunity for innovative diagnostic tools that are easy to handle and transport for early detection.

Report Coverage

This research report categorizes the market for the Japan dengue testing market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan dengue testing market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan dengue testing market.

Driving Factors

The Japan dengue testing market is driven by several factors. One of the main driving factors is the rising number of dengue cases. Another significant factor that drives the market is awareness about early diagnosis and treatment to reduce complications. Additionally, public health campaigns play an important role in increasing the knowledge about early testing and treatment, which drives the demand for dengue testing.

Restraining Factors

Despite positive driving factors dengue testing market has some challenges. One of the notable challenges in this market is limited access to healthcare infrastructure. The testing machines require high costs, which limit the market.

Market Segmentation

The Japan dengue testing market share is classified into test type and end use.

• The ELISA-based tests segment accounted for the largest share of the market in 2024 and is expected to grow at a rapid CAGR during the forecast period.

The Japan dengue testing market is segmented by test type into ELISA-based tests, dengue IgG/IgM detection kits, RT-PCR tests, rapid diagnostic tests (RDTs), NS1 antigen detection kits, and lateral flow immunoassay. Among these, the ELISA-based tests segment accounted for the largest share of the market in 2024 and is expected to grow at a rapid CAGR during the forecast period. This segmental growth is attributed to its high sensitivity, specificity, and ability to detect both dengue antigens and antibodies.

• The clinical labs segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan dengue testing market is segmented by end use into clinical labs, hospitals /clinics, and home healthcare. Among these, the clinical labs held the highest share in 2024 and are expected to grow at a significant CAGR during the forecast period. This is due to increased investment in laboratory automation. Further, the growing public health initiatives that consolidate surveillance testing in regional reference labs are propelling the market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan dengue testing market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• InBios International, Inc.
• Abbott Laboratories
• Roche Molecular Systems
• Fujifilm
• Thermo Fisher Scientific Inc.
• VisGene, Ltd.
• Eiken Chemical Co., Ltd.
• Tosoh Corporation
• Denka Co., Ltd.
• Others

Recent Developments

• In October 2023, Sysmex expanded its global immunoassay collaboration with Roche in Japan to address long-term issues in providing additional value to customers in laboratories and realizing a sustainable society.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan dengue testing market based on the below-mentioned segments:

Japan Dengue Testing Market, By Test Type

• ELISA-based Tests
• Dengue IgG/IgM Detection Kits
• RT-PCR Tests
• Rapid Diagnostic Tests (RDTs)
• NS1 Antigen Detection Kits
• Lateral Flow Immunoassay

Japan Dengue Testing Market, By End Use

• Clinical Labs
• Hospitals /Clinics
• Home Healthcare